Abnormal regulation of hexokinase in insulin-resistant skeletal muscle

The present study has assessed the potential involvement of hexokinase in the control of insulin-mediated glucose metabolism in insulin-sensitive and -resistant skeletal muscle. Soleus muscle strips fi om lean (insulin-sensitive) and obese (insulin-resistant) Zucker rats were incubated with 10 or 10,000 mu U insulin . ml(-1) and then homogenized using a protocol to maintain the location of hexokinase in. situ. Hexokinase is inhibited by glucose 6-phosphate, a metabolic intermediate which may have a central role in the regulation of glycogen synthesis. Two separate measurements of hexokinase activity were made on each muscle homogenate: the total hexokinase activity (glucose 6-phosphate was metabolized immediately by glucose 6-phosphate dehydrogenase) and the fractional hexokinase activity (glucose 6-phosphate accumulated so as to regulate the enzyme as in vivo). The total hexokinase activity was equal in insulin-sensitive and -resistant muscle and was unaffected by the extracellular insulin concentration The fractional hexokinase activity was significantly increased by insulin (10,000 mu U . ml(-1)) in all muscles (lean 82%; obese, 52%; P < 0.05) although the stimulated fractional hexokinase activity was lower in the muscle from obese Zucker rats compared to lean (P < 0.05). These results provide evidence that insulin decreases the inhibition of hexokinase by glucose 6-phosphate in insulin-sensitive but not in insulin-resistant muscle. This study has revealed shortterm regulation of hexokinase by insulin which is defective in insulin-resistant skeletal muscle. Thus, the study has identified hexokinase as a potential regulatory site of insulin action that is abnormal in insulin resistance. The altered regulation of hexokinase may be a major contributing factor to the reduced insulin-mediated glucose fluxes in insulin-resistant skeletal muscle. (C) 1996 Academic Press, Inc.